Cargando…
Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300833/ http://dx.doi.org/10.1186/bcr134 |
_version_ | 1782226369290174464 |
---|---|
author | Slamon, DJ |
author_facet | Slamon, DJ |
author_sort | Slamon, DJ |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3300833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33008332012-03-14 Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results Slamon, DJ Breast Cancer Res Oral Presentation BioMed Central 2000 2000-03-12 /pmc/articles/PMC3300833/ http://dx.doi.org/10.1186/bcr134 Text en Copyright ©2000 Current Science Ltd |
spellingShingle | Oral Presentation Slamon, DJ Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results |
title | Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results |
title_full | Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results |
title_fullStr | Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results |
title_full_unstemmed | Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results |
title_short | Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results |
title_sort | use of the anti her-2/neu antibody herceptin in the treatment of human breast cancer: biological rationale and clinical results |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300833/ http://dx.doi.org/10.1186/bcr134 |
work_keys_str_mv | AT slamondj useoftheantiher2neuantibodyherceptininthetreatmentofhumanbreastcancerbiologicalrationaleandclinicalresults |